SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 06/03/2024 at 22:15, 4 months 26 days ago

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM

Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF

published on 05/31/2024 at 12:05, 4 months 29 days ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
BRIEF

published on 05/31/2024 at 12:05, 4 months 29 days ago

Sanofi lance un plan mondial d'achat d'actions pour les salariés en 2024

Investissement Financier Sanofi Plan D'achat D'actions Pour Les Salariés Actions 2024 Participation Mondiale
PRESS RELEASE

published on 05/31/2024 at 12:00, 4 months 29 days ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
PRESS RELEASE

published on 05/31/2024 at 12:00, 4 months 29 days ago

Communiqué de presse : Sanofi lance son plan mondial 2024 d’actionnariat salarié
Sanofi lance son plan mondial 2024 d'actionnariat salarié, ouvert à 80 000 salariés dans 56 pays, offrant actions à 72,87 € avec décote de 20%. Conditions et dates clés précisées pour la souscription

Actionnariat Salarié Souscription Sanofi Plan 2024 Entreprise De Santé
BRIEF

published on 05/31/2024 at 07:10, 4 months 30 days ago

Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO

Sanofi BPCO Dupixent CHMP Approvisionnement
BRIEF

published on 05/31/2024 at 07:10, 4 months 30 days ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 4 months 30 days ago

Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO
Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO. Dupixent deviendrait la première thérapie ciblée pour la BPCO en Europe

Traitement Approbation BPCO Dupixent CHMP
PRESS RELEASE

published on 05/31/2024 at 07:05, 4 months 30 days ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 4 months 30 days ago

Sanofi finalise l’acquisition d’Inhibrx, Inc.

Acquisition Sanofi Maladies Rares Inhibrx SAR447537

Published on 10/30/2024 at 01:15, 7 hours 14 minutes ago

LQWD Grants Incentive Stock Options to Key Management
Published on 10/30/2024 at 00:10, 8 hours 19 minutes ago

Blue Lagoon Completes Private Placement
Published on 10/29/2024 at 22:10, 10 hours 19 minutes ago

Electric Metals Announces DSU and Stock Option Grant
Published on 10/29/2024 at 21:00, 11 hours 29 minutes ago

Armada Completes Amalgamation Transaction
Published on 10/29/2024 at 20:15, 12 hours 14 minutes ago

Tenth Avenue Petroleum Executes Definitive Agreement To Acquire Low Decline, Production In Southern Alberta

View all ACCESSWIRE

Published on 10/30/2024 at 08:15, 13 minutes ago

BIKE24 successfully introduces SAP S4/HANA Public Cloud
Published on 10/30/2024 at 08:10, 19 minutes ago

Evotec SE to announce results for the first nine months 2024 on 06 November 2024
Published on 10/30/2024 at 08:01, 28 minutes ago

Half Year Trading Update and Notice of Results
Published on 10/30/2024 at 08:00, 28 minutes ago

Zentra Group plc: Full year results for the year ending 30 June 2024
Published on 10/30/2024 at 08:00, 28 minutes ago

Syngenta Group Reports Q3 2024 Results

View all EQS

Published on 10/30/2024 at 08:00, 29 minutes ago

ROUGIER : Résultats du premier semestre 2024 : croissance de la rentabilité malgré une conjoncture difficile
Published on 10/30/2024 at 08:00, 29 minutes ago

ROUGIER: Half-year 2024 earnings: growth in profitability despite difficult market conditions
Published on 10/30/2024 at 07:29, 1 hour ago

Chiffre d'affaires du troisième trimestre 2024
Published on 10/30/2024 at 07:29, 1 hour ago

Third Quarter Revenues 2024
Published on 10/30/2024 at 07:01, 1 hour 28 minutes ago

bioMérieux – Third-Quarter 2024 Business Review

View all LES ECHOS COMFI WIRE

News